20270 ⎘
Medicinal preparations containing organic active ingredients; Nitriles; Isonitriles having a ring, e.g. verapamil
Method of treating a dopamine related disorder in a subject by administering levodopa, in combination with a dopamine decarboxylase inhibitor and a catechol-o-methyltransferase inhibitor
#602MESOSCALE NANOPARTICLES FOR SELECTIVE TARGETING TO THE KIDNEY AND METHODS OF THEIR THERAPEUTIC USE
#603Methods for treating and/or limiting development of diabetes in subjects with amyotrophic lateral sclerosis
#604Pharmaceutical composition containing Bay 11-7082, parthenolide or a combination thereof for the treatment of obesity or cardiovascular diseases
#605Method of treating hyperglycemia
#606Carboxy substituted (hetero) aromatic ring derivatives and preparation method and uses thereof
#607PREVENTION OF ROSACEA INFLAMMATION
#608Methods and products related to glutaminase inhibitors
#609ROR-gamma modulators and uses thereof
#610Substituted quinolinones as PDE9 inhibitors
#611Combination comprising pterostilbene for the treatment of cancer
#612NANOPARTICLES FOR SUSTAINED OPHTHALMIC DRUG DELIVERY AND METHODS OF USE
#613Anticancer agent comprising aminoacetonitrile compound as active ingredient
#614COMBINATIONS COMPRISING ANTIMUSCARINIC AGENTS AND BETA-ADRENERGIC AGONISTS
#615CANCER PROGNOSIS AND THERAPY BASED ON SYNTHEIC LETHALITY
#616Application of ethyl p-methoxycinnamate and derivatives thereof in maintaining self-renewal and pluripotency of stem cells
#617Use of substituted 2,3-dihydroimidazo[1,2-C]quinazolines for treating lymphomas
#618METHODS OF TREATING UROLOGICAL DISORDERS USING SARMs
#619SHIP1 modulators and methods related thereto
#620SYNTHETIC TRITERPENOIDS AND METHODS OF USE IN THE TREATMENT OF DISEASE
#621COMPOSITIONS AND METHODS FOR TREATMENT OF CANCER
#622Amorphous metal-organic frameworks
#623PHARMACEUTICAL COMPOSITION OF TERIFLUNOMIDE
#624Combination therapy of a HIF-2-alpha inhibitor and an immunotherapeutic agent and uses thereof
#625KCNQ potassium channel agonist, and preparation method therefor and use thereof
#626Acetylenic cyanoenones as therapeutics for inflammation and carcinogenesis
#627Substituted acethydrazide derivative, preparation method and use thereof
#628Bicyclic aryl sphingosine 1-phosphate analogs
#629TUNABLE POLYMERIC COMPOSITE COATING FOR CONTROLLED RELEASE
#630Targeting Metabolic Vulnerability in Triple-Negative Breast Cancer
#631SARMs and method of use thereof
#632Position-Specific Asymmetric Deuterium Enriched Catecholamine Derivatives And Medicaments Comprising Said Compounds
#633COMPOUNDS FOR TREATING DISORDERS ASSOCIATED WITH BK CHANNEL MODULATION
#634NOVEL TREATMENT OF PROSTATE CARCINOMA
#635Highly water-soluble salts of a short acting phenylalkylamine calcium channel blocker and uses thereof
#636Cyclic vinylogous amides as bromodomain inhibitors
#637Compositions and Methods for Enhancing Bioenergetic Status in Female Germ Cells
#638Compounds and methods for the targeted degradation of androgen receptor
#639SMALL MOLECULE CD38 INHIBITORS AND METHODS OF USING SAME
#640Monocyclic compound
#641Inhibitors of indoleamine-2,3-dioxygenase for the treatment of cancer
#6424,5-substituted picolinamide and picolinonitrile metabotropic glutamate receptor 2 negative allosteric modulators
#643Inhibitors of indoleamine-2,3-dioxygenase for the treatment of cancer
#644Treatment of circadian rhythm disorders
#645SUBSTITUTED ACYLANILIDES AND METHODS OF USE THEREOF
#646PLATFORM DRUG DELIVERY SYSTEM UTILIZING CRYSTAL ENGINEERING AND THEANINE DISSOLUTION
#647ALPHA-CINNAMIDE COMPOUNDS AND COMPOSITIONS AS HDAC8 INHIBITORS
#648Compositions for use in treating glioblastoma
#649Compositions and methods for treatment of edema
#650Methods for treating hair loss disorders
#6512,2-difluoropropionamide derivatives of bardoxolone methyl, polymorphic forms and methods of use thereof
#652Therapeutic compounds and uses thereof
#653Carboxamide derivative and its diastereomers in stable crystalline form
#654Immunomodulator compounds
#655Pesticidal active mixtures comprising isoxazoline compounds I
#656Tricyclic spiro compound
#657Bis(sulfonamide) derivatives and their use as mPGES inhibitors
#658Compounds for the treatment of mTOR pathway related diseases
#659NOVEL COMPOUND AND ANTIVIRAL AGENT CONTAINING SAME AS ACTIVE INGREDIENT
#660Selective androgen receptor degrader (SARD) ligands and methods of use thereof
#661Intranasal formulation of epinephrine for the treatment of anaphylaxis
#662Formulations For Cathepsin K Inhibitors
#663POLYMORPHS OF CDDO ETHYL ESTER AND USES THEREOF
#664Treatment of rhinosinusitis with P-glycoprotein inhibitors
#665Pyrazolone compounds having human neutrophil elastase inhibitory properties
#666High penetration drugs and their compositions thereof for treatment of Parkinson diseases
#667Mitochondrial uncouplers for treatment of metabolic diseases and cancer
#668Method of treating hyperglycemia
#669Compounds and methods for the targeted degradation of androgen receptor
#670Method for treatment of metastatic and refractory cancers and tumors with an inducer that overcomes inhibition of T cell proliferation
#671Anti-ar agent and radiation therapy for androgen receptor positive cancer
#672Methods of reducing mammographic breast density and/or breast cancer risk
#673Methods of treating hemoglobinopathies
#674Prevention of drug-induced atrio-ventricular block
#675CRUSH RESISTANT DELAYED-RELEASE DOSAGE FORMS
#676Short acting phenylalkylamine calcium channel blockers and uses thereof
#677Short acting phenylalkylamine calcium channel blockers and uses thereof
#678Short acting phenylalkylamine calcium channel blockers and uses thereof
#679INHALATION-TYPE PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF GOUT AND PREPARATION METHOD THEREOF
#680Binding molecules, especially antibodies, binding to L1CAM (CD171)
#681HIF-2α inhibitors for treating iron overload disorders
#682Coordinated metabolic reprogramming in response to productive viral infections
#683TREATMENT OF CIRCADIAN RHYTHM DISORDERS
#6844-(PHENOXYALKYL)THIO)-PHENOXYACETIC ACIDS AND ANALOGS
#685Methods and compositions for increasing the potency of antifungal agents
#686Method for treating Peyronie's disease
#687URAT1 inhibitor
#688Compounds for the treatment of paramyxovirus viral infections
#689Compositions and methods for treatment of prostate carcinoma
#690PROTEIN-PROTEIN INTERACTION INDUCING TECHNOLOGY
#691Methods for treating and/or limiting development of diabetes in subjects with amyotrophic lateral sclerosis
#692Method for treatment of inflammatory skin disorders with inhibitors of IL-36 proteolytic processing
#693Therapeutic and research application of PDCL3
#694Mast cell stabilizers treatment for systemic disorders
#695Specific mTOR inhibitors in the treatment of X-linked adrenoleukodystrophy
#696Use of EI24 gene
#697Solid forms of selective androgen receptor modulators
#698Treatment of prostate carcinoma
#699Hepatitis B antiviral agents
#700Methods of use and combinations
#701(Z)-2-CYANO-3-HYDROXY-BUT-2-ENOIC ACID-(4'-TRIFLUOROMETHYLPHENYL)-AMIDE TABLET FORMULATIONS WITH IMPROVED STABILITY
#702Bicyclic aryl sphingosine 1-phosphate analogs
#703METHOD OF TREATING PATIENTS COADMINISTERED A FACTOR Xa INHIBITOR AND VERAPAMIL
#704Pathogenic control of apoptosis
#705IDO inhibitors
#706Pharmaceutical compositions comprising levodopa, a dopamine decarboxylase inhibitor and a COMT inhibitor and method of administration thereof
#707Methods for treating cancer using iNOS-inhibitory compositions
#708SHIP1 modulators and methods related thereto
#709Use of CXCR2 Antagonists For The Prevention and/or Treatment of Chemotherapy Induced Peripheral Neuropathy (CIPN)
#710Methods for treating solid tumor cancers using a histone deacetylase inhibitor and an IκB kinase inhibitor
#711Composition for inducing differentiation of multipotent neural stem cells into dopaminergic neurons and method for inducing differentiation of multipotent neural stem cells into dopaminergic neurons by using the same
#712Method of treating HER2-positive breast cancers with selective androgen receptor modulators (SARMS)
#713Abuse-proofed dosage form
#714Aryl isonitrile compounds as a new class of potent, broad-spectrum antifungal compounds
#715CATECHOL O-METHYLTRANSFERASE ACTIVITY INHIBITING COMPOUNDS
#716CONTINUOUS ADMINISTRATION OF L-DOPA, DOPA DECARBOXYLASE INHIBITORS, CATECHOL-O-METHYL TRANSFERASE INHIBITORS AND COMPOSITIONS FOR SAME
#717COMPOSITIONS FOR TRANSDERMAL DELIVERY OF ACTIVE AGENTS
#718Immunoregulatory agents
#719Selective androgen receptor degrader (SARD) ligands and methods of use thereof
#720NOVEL ESTROGEN RECEPTOR LIGANDS
#721Position-specific asymmetric deuterium enriched catecholamine derivatives and medicaments comprising said compounds
#722Compounds and methods for inducing chondrogenesis
#723Pharmaceutical composition comprising omega-(arylsulfonyl)alkylnitrile
#724Treatment of circadian rhythm disorders
#725METHODS FOR MODULATING CANCER CELLS AND STEM CELLS
#726METHODS FOR SCREENING FOR INHIBITORS OF COMPLEMENT SERINE PROTEASES
#727KCNQ potassium channel agonists, method of preparation and method of use thereof
#728Anti-infective strategy against influenza virus and coinfections
#729Metakaryocidal treatments
#730Compounds for treating ophthalmic diseases and disorders
#731Pharmaceutical use of 3, 4-bis-benzylsulfonylbutyronitrile
#732GHRELIN O-ACYLTRANSFERASE INHIBITORS
#733Selective androgen receptor degrader (SARD) ligands and methods of use thereof
#734COMBINATIONS COMPRISING ANTIMUSCARINIC AGENTS AND PDE4 INHIBITORS
#735Formulations for Cathepsin K Inhibitors
#736Co-administration of an agent linked to an internalization peptide with an anti-inflammatory
#737Pesticidal active mixtures comprising isoxazoline compounds I
#738Natural-killer/T-cell lymphoma (NKTCL) susceptibility prediction, diagnosis and therapy
#739Non-surgical laser treatment for a fibrous mass
#740Use of malononitrile compounds for protecting animals from parasites
#741Hepatitis B antiviral agents
#742INOS-INHIBITORY COMPOSITIONS AND THEIR USE AS BREAST CANCER THERAPEUTICS
#743Induction of thyroid iodide-handling gene expression in human cancers
#744Medicament for suppressing malignant tumor metastasis
#745SARMs and method of use thereof
#746SARMs and method of use thereof
#747Sulfonamide compounds for inhibition of metastatic tumor growth
#748Method of treating HER2-positive breast cancers with selective androgen receptor modulators (SARMS)
#749Short acting phenylalkylamine calcium channel blockers and uses thereof
#750Mast cell stabilizers treatment for systemic disorders
#7514-benzylsulfonyl-2-butenenitrile
#752Mast cell stabilizers treatment for systemic disorders
#753Methods and compositions for the treatment of cancer
#754Methods and compositions for modulating hormone levels
#755Controlled release fatty acid compositions for use in body reconstruction and body-shaping
#756MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS
#757TREATMENT OF MULTIPLE SCLEROSIS WITH COMBINATION OF LAQUINIMOD AND TERIFLUNOMIDE
#758Bicalutamide analogs or (S)-bicalutamide as exocytosis activating compounds for use in the treatment of a lysosomal storage disorder or glycogenosis
#759Nested particles and the use thereof for coordinated delvery of active agents
#760Castration-resistant prostate cancer
#761Detection method for NTRK3 fusion
#762IDO inhibitors
#763Formulation Solution Adapted to Prolong Plasma Times of Drugs in Mammals Including Humans
#764Aryl isonitriles as a new class of antimicrobial compounds
#765NOVEL METHODS FOR TREATING NEURODEGENERATIVE DISEASES
#766Antidiabetic bicyclic compounds
#767MODULATION OF AXON DEGENERATION
#768Chromenone derivatives
#769Therapeutic for treating inflammatory lung disorders
#770Alpha-cinnamide compounds and compositions as HDAC8 inhibitors
#771Platform drug delivery system utilizing crystal engineering and theanine dissolution
#772Platform drug delivery system utilizing crystal engineering and theanine dissolution
#773Platform drug delivery system utilizing crystal engineering and theanine dissolution
#774Methods for treating hair loss disorders
#775Methods for treating hair loss disorders
#776Parasiticidal compositions comprising benzimidazole derivatives, methods and uses thereof
#777Anthraquinone compounds and their uses
#778Methods for treating and/or limiting development of diabetes in subjects with amyotrophic lateral sclerosis
#779Pharmaceutical combinations for the treatment of cancer
#780Bisarylsulfonamides useful in the treatment of inflammation and cancer
#781Compositions and methods for treatment of diabetic retinopathy
#782Identification of small molecules that facilitate therapeutic exon skipping
#783KINASE INHIBITORS FOR THE TREATMENT OF CANCER
#784Intranasal Formulation for the Treatment of Cardiopulmonary Resuscitation (CPR), Cardiac Life Support (CLS), Anaphylaxis and/or Anaphylactoid Reactions
#785Anticancer agent comprising aminoacetonitrile compound as active ingredient
#786Amide derivatives as lysophosphatidic acid receptor antagonists
#787Pharmaceutical use of 3-benzylsulfonylpropionitrile
#788MITOCHONDRIA AND HUMAN IMMUNODEFIENCY VIRUS TYPE 1 TRANSMISSION
#789Cyclic vinylogous amides as bromodomain inhibitors
#790Inhibition of thymine DNA glycosylase in the treatment of cancer
#7914-(phenoxyalkyl)thio)-phenoxyacetic acids and analogs
#792Aniline derivatives, their preparation and their therapeutic application
#793Treatment of rhinosinusitis with P-glycoprotein inhibitors
#794Diagnostic markers for multiple sclerosis
#795Functionalized magnetic nanoparticles and use in imaging amyloid deposits and neurofibrillary tangles
#796Crush resistant delayed-release dosage forms
#797METHOD OF TREATING DISORDERS OF THE CARDIOVASCULAR SYSTEM AND A PHARMACEUTICAL AGENT
#798Selective androgen receptor modulator and methods of use thereof
#799Formulations for Cathepsin K Inhibitors with Vitamin D
#800Modulation of axon degeneration
#801Methods and treatments for the learning and memory deficits associated with Noonan syndrome
#802SARMs and method of use thereof
#803Combination treatment of cancer
#804Continuous administration of dopa decarboxylase inhibitors and compositions for same
#805Compositions and methods for the treatment of fungal infections
#806Immunoregulatory agents
#807IDO inhibitors
#8081,3-diaminocyclopentane carboxamide derivatives
#809Bicyclic aryl sphingosine 1-phosphate analogs
#810SOLID FORMS OF SELECTIVE ANDROGEN RECEPTOR MODULATORS
#811Method of treating androgen receptor (AR)-positive breast cancers with selective androgen receptor modulator (SARMs)
#812CRUSH RESISTANT DELAYED-RELEASE DOSAGE FORMS
#813Cycloalkyl acid derivative, preparation method thereof, and pharmaceutical application thereof
#814Topical therapeutic formulations
#815METHODS OF TREATING UROLOGICAL DISORDERS USING SARMs
#816PHARMACEUTICAL COMPOSITIONS COMPRISING DROXIDOPA
#817ASSAYS, METHODS AND KITS FOR ANALYZING SENSITIVITY AND RESISTANCE TO ANTI-CANCER DRUGS, PREDICTING A CANCER PATIENT'S PROGNOSIS, AND PERSONALIZED TREATMENT STRATEGIES
#818SUBSTITUTED ACYLANILIDES AND METHODS OF USE THEREOF
#819METHOD FOR PRODUCING DOSAGE FORM COMPRISING ODANACATIB
#820TABLET WITH INCREASED DRUG LOAD OF ODANACATIB
#821Use of substituted 2,3-dihydroimidazo[1,2-c]quinazolines for treating lymphomas
#822Methods for treating hair loss disorders
#823Methods for treating hair loss disorders
#824PHARMACEUTICAL COMPOSITIONS OF TERIFLUNOMIDE
#825N-hydroxymethanesulfonamide nitroxyl donors
#826Compounds useful for the treatment of metabolic disorders and synthesis of the same
#827Compounds and methods for inducing chondrogenesis
#828PHENYLCYCLOPROPYLAMINE DERIVATIVES AND THEIR MEDICAL USE
#829CACNA1C ALLELE AND TREATMENT OF MOOD DISORDERS
#830Bicyclo[2.2.2]acid GPR120 modulators
#831Treatment of staphylococcal disorders
#832Prevention of rosacea inflammation
#833Formulation containing carbidopa, levodopa, and entacapone
#834METHOD FOR TREATMENT OF PARKINSON'S DISEASE
#835COMPOSITIONS AND METHODS FOR PHYSIOLOGICAL DELIVERY USING CANNABIDIOL
#836Treatment of demyelinating disorders
#837Extended Release Pharmaceutical Composition Of Entacapone Or Salts Thereof
#838High penetration drugs and their compositions thereof for treatment of parkinson diseases
#839Sulfamoyl-arylamides and the use thereof as medicaments for the treatment of hepatitis B
#840CYCLOPROPYLAMINE INHIBITORS OF OXIDASES
#841Methods and compositions for treating obesity, preventing weight gain, promoting weight loss, promoting slimming, or treating or preventing the development of diabetes
#842Methods of inhibiting IGF-1R activation or downtream signalling thereof to reduce radiation-induced cellular senescence
#843N-prop-2-ynyl carboxamide derivatives and their use as TRPA1 antagonists
#844Crush resistant delayed-release dosage forms
#845Compositions and methods for treatment of cancer
#846Opsin-binding ligands, compositions and methods of use
#847INDUCTION OF ESTROGEN RECEPTOR BETA BY CHOLESTEROL BIOSYNTHESIS INHIBITORS AND METHODS OF TREATMENT OF CANCER
#848Acylguanidines for treating osteoarthritis
#849Methods and compositions for treatment of demyelinating diseases
#850Compositions and Methods of Reducing Sedation
#851Treatment of prostate carcinoma
#852Compositions and methods for treating skin cancer associated diseases
#853PDK4 INHIBITOR AND USE THEREOF
#854CANCER PROGNOSIS AND THERAPY BASED ON SYNTHEIC LETHALITY
#855Pyridazinones as DAAO enzyme inhibitors
#856Ophthalmic solution for absorbing ultraviolet radiation and method for absorbing ultraviolet radiation
#857Enzyme inhibitors
#858PHENYLTHIOACETATE COMPOUNDS, COMPOSITIONS AND METHODS OF USE
#859Deuterated compounds and uses thereof
#860COMPOSITIONS OF ALDH1A1 INHIBITORS AND METHODS OF USE IN TREATING CANCER
#861COMBINATIONS COMPRISING ANTIMUSCARINIC AGENTS AND PDE4 INHIBITORS
#862(Het)aryl-p-quinone derivatives for treatment of mitochondrial diseases
#863Compounds useful as immunomodulators
#864Methods of treating muscular dystrophy
#865Combination of HMG-CoA reductase inhibitors with phosphodiesterase 4 inhibitors for the treatment of inflammatory pulmonary diseases
#866Inhalation-type pharmaceutical composition for the treatment of arthritis and preparation method thereof
#867Inhalation-type pharmaceutical composition for the treatment of heart disease and preparation method thereof
#868Inhalation-type pharmaceutical composition for the treatment of Alzheimer's disease and preparation method thereof
#869Inhalation-type pharmaceutical composition for the treatment of Parkinson's disease and preparation method thereof
#870USE OF ELECTROPHILIC COMPOUNDS FOR INDUCING PLATELET PRODUCTION OR MAINTAINING PLATELET FUNCTION
#8712,2-difluoropropionamide derivatives of bardoxolone methyl, polymorphic forms and methods of use thereof
#872Use of miR-221 and 222 lowering agents to prevent cardiovascular disease in diabetic subjects
#873TREATMENT OF AUTOPHAGY-BASED DISORDERS AND RELATED PHARMACEUTICAL COMPOSITIONS, DIAGNOSTIC AND SCREENING ASSAYS AND KITS
#874COMPOSITION FOR INHIBITION OF CATHEPSIN K
#875Compounds for use in the treatment of mycobacterial infections
#876Catechol O-methyltransferase activity inhibiting compounds
#877Therapeutic for Treating Inflammatory Lung Disorders
#878Agents useful for treating obesity, diabetes and related disorders
#879Compounds and methods for treating mammalian gastrointestinal microbial infections
#880Methods to inhibit intracellular growth of bacteria and to treat bacteria-mediated diseases
#881Aryloxyurea compound and pest control agent
#882Compounds for use as inhibitors of alternative oxidase or cytochrome BC1 complex
#883Substituted aminoindane- and aminotetralinecarboxylic acids and the use thereof
#884Parasiticidal compositions comprising benzimidazole derivatives, methods and uses thereof
#885Compounds for the treatment of mTOR pathway related diseases
#886Combination of DNA repair inhibition with bendamustine or gemcitabine in the treatment of cancer
#887Method of quenching singlet and triplet excited states of pigments, such as porphyrin compounds, particularly protoporphyrin IX, with conjugated fused tricyclic compounds have electron withdrawing groups, to reduce generation of reactive oxygen species, particularly singlet oxygen
#888COMBINATION THERAPY FOR TREATMENT OF MULTIPLE SCLEROSIS
#889INHIBITORS OF HIPPO-YAP SIGNALING PATHWAY
#890Sustained release dosage form
#891Topical therapeutic formulations
#892METHODS AND PRODUCTS RELATED TO LUNG CANCER
#893Use of levodopa, carbidopa and entacapone for treating Parkinson's disease
#894Indanyloxyphenylcyclopropanecarboxylic acids
#895INHIBITORS OF ERK FOR DEVELOPMENTAL DISORDERS OF NEURONAL CONNECTIVITY
#896Pyrethroids for treatment of ocular movement disorders
#897Pharmaceutical compositions for treatment of Parkinson's disease
#898Sorafenib derivatives as p21 inhibitors
#899Co-administration of an agent linked to an internalization peptide with an anti-inflammatory
#900Modulator compounds of drug resistance in epithelial tumor cells